Cholera News and Research

Latest Cholera News and Research

Blog reports on case of 'U.N. cholera denial' in Zimbabwe

"There is understandable outrage over the United Nation's reaction to its role in first creating and then denying responsibility for Haiti's cholera outbreak in 2010 that killed 8,000 people," Todd Moss, vice president for programs and senior fellow at the Center for Global Development (CGD), writes in the center's "Global Health Policy" blog.

11 Mar 2013

Editorial, opinion piece address U.N.'s denial of claims for compensation for Haiti cholera victims

The U.N. in February denied claims for compensation from 5,000 victims of the Haiti cholera epidemic, stating the claims were "non-receivable" under article 29 of the Convention on the Privileges and Immunities of the United Nations.

6 Mar 2013

Haiti launches $2.2B, 10-year plan to eradicate cholera

"The Haitian government's $2.2 billion, 10-year plan to eradicate cholera was launched on Wednesday against the backdrop of the U.N.'s rejection of a legal claim from more than 5,000 victims" that sought compensation for the cholera epidemic, which "has killed more than 8,000 people and infected nearly 648,000" and is thought to have been started by a U.N. peacekeeping mission, the Guardian reports.

1 Mar 2013

U.N.'s assertion of immunity in cholera outbreak is morally, legally 'right' decision

"When U.N. Secretary-General Ban Ki-moon invoked diplomatic immunity last week for peacekeepers who unwittingly caused the cholera outbreak that killed nearly 8,000 Haitians, his decision looked cold-hearted," but "sympathy for Haitians should not mask the necessity of the secretary-general's decision," Boston Globe correspondent Juliette Kayyem writes in an opinion piece in the newspaper.

1 Mar 2013

U.N.'s legal immunity, refusal to compensate Haitians for cholera claims 'cheapens its larger mission'

Noting the U.N. last week "announced that Haitian claims for compensation weren't receivable under article 29 of the Convention on the Privileges and Immunities of the United Nations," Armin Rosen, a writer and producer for The Atlantic's international channel, writes in an opinion piece in the magazine, "If a multinational corporation behaved the way the U.N. did in Haiti, it would be sued for stratospheric amounts of money."

28 Feb 2013

U.N. must do more to fight cholera in Haiti

Noting U.N. Secretary-General Ban Ki-moon last week cited diplomatic immunity in "reject[ing] a legal claim for compensation filed in 2011 on behalf of cholera victims in Haiti," Louise Ivers, a senior health and policy adviser at Partners In Health, writes in a New York Times opinion piece, "Regardless of the merits of this argument, the United Nations has a moral, if not legal, obligation to help solve a crisis it inadvertently helped start."

26 Feb 2013

Families of Haitian cholera victims react to U.N. decision to deny compensation for deaths

"The United Nations has come under heavy political fire for its decision to deny compensation for thousands of victims of cholera in Haiti -- a deadly disease spread by U.N. peacekeepers in the troubled Caribbean nation," Inter Press Service reports.

26 Feb 2013

U.N. claims 'legal immunity' in case seeking compensation for Haiti cholera outbreak; Ban reiterates commitment to eliminating the disease

"The U.N. has taken the rare step of invoking its legal immunity to rebuff claims for compensation from 5,000 victims of the Haiti cholera epidemic, the worst outbreak of the disease in modern times and widely believed to have been caused by U.N. peacekeepers importing the infection into the country," the Guardian reports.

23 Feb 2013

Chagas disease costs $7B annually worldwide, according to study

Chagas disease, transmitted by a bloodsucking insect that bites the face and lips, "costs the world about $7 billion annually, says an analysis just published in the Lancet Infectious Diseases," NPR's "Shots" blog reports.

12 Feb 2013

Cholera cases confirmed in northern Mozambique after heavy rains, flooding

"In the last 10 days, 22 cases of the waterborne disease cholera have been confirmed by laboratory testing in three areas in and around the northern Mozambique town of Pemba, in Cabo Delgado Province," IRIN reports.

12 Feb 2013

Microbiologists discover new pathway to improve vaccines against tuberculosis

A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.

1 Feb 2013

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

PaxVax, Inc., which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced positive results in a Phase 1 clinical trial for its oral, replicating adenovirus serotype 4 (Ad4) vector vaccine for H5N1 (avian flu).

31 Jan 2013

Viewpoints: Gov. Jindal calls Medicaid an 'outdated model;' GOP's opposition to 'Big Government' hurts effort to revamp entitlements

As the implementation of Obamacare unfortunately nears, every governor must decide whether to expand Medicaid. This is not a simple question. Expanding Medicaid will significantly burden state budgets across the country.

29 Jan 2013

Focus water, sanitation investments on cholera risk zones, aid groups say

"Aid groups are urging donors to invest in water and sanitation in areas known as hotbeds for cholera," saying "while such projects might directly affect a relatively small population, the indirect impact in terms of cholera reduction could be immense," IRIN reports.

29 Jan 2013

G-CON completes delivery and installation of POD system in PaxVax's GMP production facility

G-CON today announced the completed delivery and installation of the ground-breaking POD system in PaxVax's licensed GMP production facility based in San Diego, California where PaxVax manufactures innovative and socially responsible oral vaccines against infectious diseases.

19 Jan 2013

Deriving lessons from cholera epidemic in Haiti and looking forward to future actions

Noting U.N. peacekeepers played a role in bringing cholera to Haiti, Victoria Fan, a research fellow at the Center for Global Development (CGD), writes in the group's "Global Health Policy" blog, "Blame aside, there are undoubtedly lessons to be learned by looking back at how this epidemic came to pass in Haiti. More importantly, looking ahead there are key steps that should be taken to eliminate cholera in Haiti."

19 Jan 2013

New menu of 61 genetically engineered E. coli strains may improve efficacy of vaccines

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.

17 Jan 2013

Cuban authorities work to contain cholera outbreak in capital city

"Cuban authorities are scrambling to contain a cholera outbreak that has sickened dozens of people in Havana, the capital city of 2.2 million residents and a popular tourism destination," Reuters reports.

17 Jan 2013

Addressing cholera with an 'integrated approach' in 2013

"There has been so much news related to cholera and cholera research since the start of 2013 I can only hope it means this year will be a banner year for prevention efforts," Helen Matzger, a program officer in new vaccine delivery at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.

16 Jan 2013

NPR's 'Shots' blog examines cholera epidemic in Haiti; U.N. SG calls for continued international support of country

NPR's "Shots" blog examines the cholera epidemic in Haiti and addresses the controversy surrounding the U.N.'s role in the outbreak, noting, "Most scientists now think Nepalese soldiers unwittingly brought cholera to Haiti when they joined a U.N. peacekeeping force there in 2010."

16 Jan 2013

Cholera News and Research

Latest Cholera News and Research

Blog reports on case of 'U.N. cholera denial' in Zimbabwe

Editorial, opinion piece address U.N.'s denial of claims for compensation for Haiti cholera victims

Haiti launches $2.2B, 10-year plan to eradicate cholera

U.N.'s assertion of immunity in cholera outbreak is morally, legally 'right' decision

U.N.'s legal immunity, refusal to compensate Haitians for cholera claims 'cheapens its larger mission'

U.N. must do more to fight cholera in Haiti

Families of Haitian cholera victims react to U.N. decision to deny compensation for deaths

U.N. claims 'legal immunity' in case seeking compensation for Haiti cholera outbreak; Ban reiterates commitment to eliminating the disease

Chagas disease costs $7B annually worldwide, according to study

Cholera cases confirmed in northern Mozambique after heavy rains, flooding

Microbiologists discover new pathway to improve vaccines against tuberculosis

Positive results from PaxVax's Ad4-H5-Vtn vector vaccine Phase 1 trial on avian flu

Viewpoints: Gov. Jindal calls Medicaid an 'outdated model;' GOP's opposition to 'Big Government' hurts effort to revamp entitlements

Focus water, sanitation investments on cholera risk zones, aid groups say

G-CON completes delivery and installation of POD system in PaxVax's GMP production facility

Deriving lessons from cholera epidemic in Haiti and looking forward to future actions

New menu of 61 genetically engineered E. coli strains may improve efficacy of vaccines

Cuban authorities work to contain cholera outbreak in capital city

Addressing cholera with an 'integrated approach' in 2013

NPR's 'Shots' blog examines cholera epidemic in Haiti; U.N. SG calls for continued international support of country

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Cholera News and Research

Latest Cholera News and Research

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Newsletters you may be interested in